The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Patient-reported Outcomes and the Economic Effects of Non-Alcoholic Fatty Liver Diseaseand Non-alcoholic Steatohepatitis - The Value Proposition
Younossi ZM1. Hepatology. 2018 Aug 2. doi: 10.1002/hep.30125. [Epub ahead of print]
Author information
1
Betty and Guy Beatty Center for Integrated Research, Claude Moore Health Education and Research Building, 3300 Gallows Road, Falls Church, VA, 22042.
Abstract
Nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) can progress to cirrhosis, death, or livertransplantation. NASH has also been associated with impaired health-related quality of life and poses a significant economic burden. Due to the negative clinical and patient-reported outcomes and economic burden of NASH, it is necessary to review NAFLD through the lens of the value-based care, in which value is proportional to clinical and quality outcomes and inversely proportional to costs of these outcomes. We review the components of outcomes measured for patients with NAFLD and NASH and relate them to the value proposition, with an aim to optimize patient care. This article is protected by copyright. All rights reserved.